These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34168405)

  • 1. Liver injury in COVID-19: Detection, pathogenesis, and treatment.
    Cai Y; Ye LP; Song YQ; Mao XL; Wang L; Jiang YZ; Que WT; Li SW
    World J Gastroenterol; 2021 Jun; 27(22):3022-3036. PubMed ID: 34168405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver diseases in COVID-19: Etiology, treatment and prognosis.
    Wu J; Song S; Cao HC; Li LJ
    World J Gastroenterol; 2020 May; 26(19):2286-2293. PubMed ID: 32476793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of COVID-19 on Liver Injury.
    Dawood DRM; Salum GM; El-Meguid MA
    Am J Med Sci; 2022 Feb; 363(2):94-103. PubMed ID: 34752738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-associated liver injury: from bedside to bench.
    Li D; Ding X; Xie M; Tian D; Xia L
    J Gastroenterol; 2021 Mar; 56(3):218-230. PubMed ID: 33527211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and multiorgan failure: A narrative review on potential mechanisms.
    Mokhtari T; Hassani F; Ghaffari N; Ebrahimi B; Yarahmadi A; Hassanzadeh G
    J Mol Histol; 2020 Dec; 51(6):613-628. PubMed ID: 33011887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.
    Wang H; Qiu P; Liu J; Wang F; Zhao Q
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):653-661. PubMed ID: 32418852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of coronavirus disease 2019 (COVID-19) on liver injury in China: A systematic review and meta-analysis.
    Zhao X; Lei Z; Gao F; Xie Q; Jang K; Gong J
    Medicine (Baltimore); 2021 Jan; 100(4):e24369. PubMed ID: 33530232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver injury in COVID-19: clinical features and treatment management.
    Yu D; Du Q; Yan S; Guo XG; He Y; Zhu G; Zhao K; Ouyang S
    Virol J; 2021 Jun; 18(1):121. PubMed ID: 34108015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and the liver: A 2021 update.
    Spearman CW; Aghemo A; Valenti L; Sonderup MW
    Liver Int; 2021 Sep; 41(9):1988-1998. PubMed ID: 34152690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic complications of COVID-19 and its treatment.
    Tian D; Ye Q
    J Med Virol; 2020 Oct; 92(10):1818-1824. PubMed ID: 32437004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.
    Zhang H; Liao YS; Gong J; Liu J; Zhang H
    World J Gastroenterol; 2020 Aug; 26(31):4694-4702. PubMed ID: 32884226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
    Lai CC; Shih TP; Ko WC; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2020 Mar; 55(3):105924. PubMed ID: 32081636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
    Taher T; Sheikh AB; Anwar F; Khosa F
    Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in clinical characteristics and liver injury between suspected and confirmed COVID-19 patients in Jingzhou, Hubei Province of China.
    Zhang Q; Li J; Zhang Y; Gao J; Wang P; Ai M; Ding W; Tan X
    Medicine (Baltimore); 2021 May; 100(19):e25913. PubMed ID: 34106656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology and management of liver injury in patients with COVID-19.
    Yang RX; Zheng RD; Fan JG
    World J Gastroenterol; 2020 Aug; 26(32):4753-4762. PubMed ID: 32921955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology and clinical information about COVID-19.
    Ge H; Wang X; Yuan X; Xiao G; Wang C; Deng T; Yuan Q; Xiao X
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1011-1019. PubMed ID: 32291542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
    Lai CC; Liu YH; Wang CY; Wang YH; Hsueh SC; Yen MY; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):404-412. PubMed ID: 32173241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of the emergency department in screening and diagnosis of COVID-19 in China.
    Zhang Q; Pan J; Zhao MX; Lu YQ
    J Zhejiang Univ Sci B; 2020 May; 21(5):388-393. PubMed ID: 32425004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms.
    Du M; Yang S; Liu M; Liu J
    Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101793. PubMed ID: 34428501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of COVID-19, Disease Outbreak: A Review.
    Sharma H; Singh S; Pathak S
    Curr Pharm Biotechnol; 2021; 22(12):1591-1601. PubMed ID: 33504302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.